NRX Pharmaceuticals Q1 EPS $(0.04) Up From $(0.34) YoY, Sales $1.068M

Benzinga Newsdesk www.benzinga.com Negative 50.8%

Neg 50.8% Neu 0% Pos 0%

NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly losses of $(0.04) per share. This is a 88.24 percent increase over losses of $(0.34) per share from the same period last year. The company reported $1.068 million in sales this quarter.